Delivery Order SPE2DB22D3004-SPE2DB25FRV25
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,047.16 to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 11, 2025, with completion scheduled for August 12, 2025. This delivery order was awarded on a firm fixed price basis without set-aside designation, indicating competitive award to this established pharmaceutical vendor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal 100 mg tablets (100 count) on January 2, 2026, with a ceiling value of $1,864.46 and an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,579.11 to AmerisourceBergen Drug Corp for the supply of Lamictal 25 mg tablets (100 count) on July 22, 2025, with a completion date of July 23, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal 25 mg tablets (100-count units) valued at $19,868.41 on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 13, 2025, with a ceiling value of $2,273.15. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $20,514.17 to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg, a pharmaceutical product commonly used to treat neurological conditions. This non-set-aside, competitively awarded contract employs firm fixed price pricing and was executed on November 24, 2025, with an ultimate completion date of November 25, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,233.26 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Lamotrigine ODT 50 mg tablets in quantities of 30. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 16, 2025. This delivery order was competitively awarded with firm fixed pricing and carries no set-aside designation. This delivery order is issued under...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $3,318.84, is for the supply of 100 tablet bottles of the prescription drug Lamictal (Lamotrigine) 25 milligrams. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA that has a...
- The Defense Logistics Agency awarded a $7,605.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Lamictal XR 250 mg, a pharmaceutical product for neurological treatment. The contract was awarded on December 16, 2025, with an ultimate completion date of December 17, 2025, and utilizes no set-aside designation. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $5,392.65 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to supply 100 tablets of 100 milligram Lamictal at the place of performance in Conshohocken, Pennsylvania. The delivery order was issued on July 10, 2023 under an existing contract vehicle and requires delivery by July 11, 2023. As the primary logistics and procurement agency supporting the...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRV25Delivery Order
The Defense Logistics Agency awarded a $1,596.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Lamictal 100 mg, with performance in Conshohocken, Pennsylvania and completion by August 5, 2025. This delivery order represents a non-set-aside, competitively awarded transaction executed on August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, and specialized medical supplies. The award demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements through open competition and its established role within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/4/25 |